Absci to report business updates and second quarter 2025 financial and operating results on august 12, 2025

Vancouver, wash. and new york, july 30, 2025 (globe newswire) -- absci corporation (nasdaq: absi), a clinical-stage biopharmaceutical company advancing breakthrough therapeutics with generative design, today announced the company will report business updates and financial and operating results for the second quarter 2025 after market close on tuesday, august 12, 2025.
ABSI Ratings Summary
ABSI Quant Ranking